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Summary
 
Bipotential T/natural killer (NK) progenitor cells are present in the human thymus. Despite
their bipotential capacity, these progenitors develop predominantly to T cells in the thymus.
The mechanisms controlling this developmental choice are unknown. Here we present evi-
dence that a member(s) of the family of basic helix loop helix (bHLH) transcription factors de-
termines lineage specification of NK/T cell progenitors. The natural dominant negative HLH
factor Id3, which blocks transcriptional activity of a number of known bHLH factors, was ex-
pressed in CD34
 
1
 
 progenitor cells by retrovirus-mediated gene transfer. Constitutive expres-
sion of Id3 completely blocks development of CD34
 
1
 
 cells into T cells in a fetal thymic organ
culture (FTOC). In contrast, development into NK cells in an FTOC is enhanced. Thus, the
activity of a bHLH transcription factor is necessary for T lineage differentiation of bipotential
precursors, in the absence of which a default pathway leading to NK cell development is cho-
sen. Our results identify a molecular switch for lineage specification in early lymphoid precur-
sors of humans.
 
T
 
he earliest progenitor cells in the thymus have the ca-
pacity of developing into multiple hematopoietic lin-
eages. Upon further development within the thymus, these
progenitor cells progressively lose their multipotentiality
(1). There is considerable evidence that the human (2) and
the mouse thymuses (3, 4) contain bipotential T/NK pro-
genitors. However, given the paucity of mature NK cells in
the thymus, the thymic environment strongly favors devel-
opment of these bipotential T/NK progenitor cells into
T cells. The molecular mechanisms controlling T/NK lin-
eage specification in the thymus are not yet elucidated, but
it seems fair to assume that this developmental choice is un-
der transcriptional control.
Several transcription factors that orchestrate lymphoid
development have now been identified in the mouse. Ikaros
is a key factor that affects development of all lymphoid (T,
NK, and B) cells (5). Several other factors appear to be crit-
ical for development of specific lymphoid lineages like
GATA-3 (6) and TCF-1 (7) for T cells and Pax5 (8), EBF
(9), Sox4 (10), and the products of the E2A gene (11, 12)
for B cells. The E2A proteins E12 and E47 belong to the
family of basic helix loop helix (bHLH) transcription fac-
tors, which are involved in differentiation of many cell types
(13). E12 and E47 probably regulate B cell development by
controlling expression of immunoglobulin, RAG, and a
number of B cell–specific genes including mb-1, 
 
l
 
5,
CD19, and Pax5 (11, 12, 14). Transcriptional activity of
bHLH factors is controlled by the inhibitor of DNA bind-
ing (Id) proteins. This family of HLH factors comprises
four members, Id1, 2, 3, and 4, which are highly homolo-
gous in their HLH domains and have distinct tissue distri-
butions (15, 16). Id factors can heterodimerize with bHLH
factors, but lack a basic DNA binding domain, and there-
fore they block transcriptional activity by bHLH factors.
Constitutive overexpression of Id1 under control of a B
cell–specific mb-1 promotor leads to inhibition of B cell
development (17), similar to the one observed in E2A-defi-
cient animals (11, 12).
Recent evidence has suggested a role for bHLH factors in
development of T cells as well. E2A-deficient mice were
initially reported to have no gross abnormalities in T cell de-
velopment, but the size of the thymus is smaller than that of
wild-type animals (12). Mice deficient for another bHLH
factor, HEB, displayed a partial block in T cell development
at an early stage of development (18). Whether HEB and
E2A deficiencies affect NK cell development is not known.
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Id3 Inhibits Human T Cell Development
 
In this paper we have investigated the role of bHLH fac-
tors in human T and NK cell development. We have made
use of retrovirus-mediated gene transfer to enforce expres-
sion of one of the Id proteins, Id3, in CD34
 
1
 
 progenitors
using a bicistronic vector harboring Id3 and the marker gene
green fluorescent protein (GFP). Id3 can interact with a
wide range of bHLH factors and blocks transcriptional ac-
tivity of E12, E47, and HEB (19). We found that enforced ex-
pression of Id3 strongly inhibits development of CD34
 
1
 
progenitors to CD3
 
1
 
 T cells in an in vitro fetal thymic or-
gan culture (FTOC), but promotes development of NK cells.
 
Materials and Methods
 
Construction of the Vectors and Transduction of Target Cells.
 
Pre-
viously we have successfully used bicistronic vectors with a gene
of interest linked to a downstream internal ribosomal entry site
(IRES) and a marker gene that allow independent translation of
the products of both genes in the transduced target cells (20). The
IRES-GFP sequence was ligated into the LZRS vector (21), and
a polylinker was placed downstream of the gag and upstream of
the IRES sequences. The Id3 coding sequence was cloned from
the pCDNAId3 (gift of Dr. C. Murre, University of California at
San Diego, San Diego, CA) plasmid by PCR using oligonucle-
otide primers with appropriate linkers. The product was ligated
between the XhoI and SnaBI site of the polylinker from our plas-
mid LZRS-linker-IRES-GFP, to obtain the retroviral vector
LZRS-Id3-IRES-GFP. (A modified version of GFP [enhanced
GFP] was used in this study and was obtained from Clontech,
Palo Alto, CA.) Helper-free recombinant retrovirus was pro-
duced after transfection into a 293T-based amphotropic retroviral
packaging cell line, Phoenix (21). Purified CD34
 
1
 
 cells were cul-
tured for 24 h in the presence of 10 ng/ml human IL-7 and 10
ng/ml stem cell factor (SCF) (both from R&D, Abingdon, UK).
The cells were then transduced by overnight incubation with vi-
rus supernatant in the presence of 10 
 
m
 
g/ml Dotap (Boehringer
Mannheim GmbH, Mannheim, Germany).
 
Isolation of CD34
 
1
 
 Cells from Fetal Liver and Postnatal Thy-
mus.
 
Fetal liver was obtained from elective therapeutic abor-
tions. Gestational age was determined by crown–rump length and
ranged from 14 to 17 wk. The use of this tissue was approved by
the medical ethical committee of the Netherlands Cancer Institute
and was contingent upon informed consent. Human fetal liver
cells were isolated by gentle disruption of the tissue by mechani-
cal means, followed by density gradient centrifugation over Fi-
coll-Hypaque (Lymphoprep; Nycomed Pharma, Oslo, Norway).
The CD34
 
1
 
 cells were isolated from these samples by immuno-
magnetic cell sorting, using a CD34 separation kit (varioMACS;
Miltenyi Biotec, Bergisch Gladbach, Germany) and were further
purified by sorting with a FACStar plus
 
Ò
 
 (Becton Dickinson, San
José, CA). Postnatal thymus samples were from children under-
going open-heart surgery. CD34
 
1
 
 cells, enriched by immuno-
magnetic cell sorting, were labeled with anti-CD34 (HPCA-2;
Becton Dickinson) and anti-CD1a (Coulter, Hialeah, FL) anti-
bodies and the CD34
 
1
 
CD1a
 
2
 
 cells were purified by FACS
 
Ò
 
 sort-
ing. The purity of the populations used in this study was 
 
.
 
99%.
 
Fetal Thymic Organ Cultures.
 
In vitro development of human
T and NK cells from CD34
 
1
 
 fetal liver cells or thymocytes was
studied using the hybrid human/mouse FTOC using fetal thy-
muses from embryos of RAG-1–deficient mice as described (22).
TCR-
 
g
 
/
 
d
 
1
 
 and NK cells were expanded in Yssels medium (23)
 
from the FTOC cultures using a feeder cell mixture as described
previously (24).
 
NK Cell Assays.
 
10,000 CD34
 
1
 
 sorted cells were cultured in
Yssels medium in the presence of 10 ng/ml SCF, 10 ng/ml IL-7,
and 100 U/ml IL-2 (Eurocetus, Amsterdam, Netherlands). After
1 wk, cells were harvested, counted, and analyzed by FACS
 
Ò
 
, us-
ing anti-CD3 and anti-CD56 (provided by Dr. J.H. Phillips,
DNAX, Palo Alto, CA). The cytotoxic activity of NK cells was
determined with a standard 
 
51
 
Cr–release assay using cells of NK-
sensitive (K562) and insensitive (the EBV-transformed B cell line
EBV225) cell lines as target cells.
 
Analysis of D-J
 
b
 
 Rearrangements.
 
D-J
 
b
 
 rearrangements were
determined by PCR as described previously (25). Primers and
probes used for TCR-
 
b
 
 rearrangement were: 5-TGGTGGTC-
TCTCCCAGGCTCT-3
 
9
 
 (D
 
b
 
1.1), 5
 
9
 
-CCAGCTGTCCAGC-
CTTGACTT-3
 
9
 
 (J
 
b
 
1.3-1.4) and 5
 
9
 
-CAAAGCTGTAACAT-
TGTGGGGAC-3
 
9
 
 (D
 
b
 
pan
 
 probe). To control for the amount of
DNA in the PCR, genomic amplification of the RAG-2 gene was
performed. Primers and probe used were: 5
 
9
 
-TGTGAATTGCA-
CAGTCTTGCCAGG-3
 
9
 
 (RAG-2 sense), 5
 
9
 
-GGGTTTGT-
TGAGCTCAGTTGAATAG-3
 
9
 
 (RAG-2 antisense), and 5
 
9
 
-
CAAGATATGGTTTGGAAGCAACATGGGAAA-3
 
9
 
 (RAG-2
probe).
 
Results and Discussion
 
Enforced Expression of Id3 Inhibits Development of
CD1a
 
2
 
CD34
 
1
 
 Thymocytes, but Promotes NK Development in
an FTOC.
 
To study the role of bHLH factors in T cell
development, we overexpressed the dominant negative
HLH protein Id3 in T cell progenitors and monitored the
fate of the transduced cells. Id3 has a very broad tissue dis-
tribution and CD34
 
1
 
 fetal liver and thymic progenitor cells
express Id3 messenger RNA as determined by reverse tran-
scription PCR (results not shown). Purified CD34
 
1
 
 fetal
liver cells were cultured with a combination of SCF and
IL-7 for 24 h. The cells were then transduced by overnight
coculture with supernatants of packaging cells producing
recombinant viruses harboring either Id3-IRES-GFP or
IRES-GFP, and cultured in an FTOC for 4 wk (22). The
flow cytometric analysis shown in Fig. 1 demonstrates that
the GFP marker was transferred to 23% of the progeny of
the IRES-GFP and 13% of the Id3-IRES-GFP–transduced
progenitor cells. The patterns of CD3, CD4, and CD5 stain-
ings of the GFP
 
1
 
 cells from the IRES-GFP–transduced cells
are identical to that of the nontransduced GFP
 
2
 
 cells (Fig.
1). The great majority of the GFP
 
1
 
 cells express CD1a, and
very few CD56
 
1
 
 cells were present in these samples. By
contrast, cells harvested from the FTOC with Id3-IRES-
GFP–transduced fetal liver cells did not express CD1a, and
32% of these cells were positive for the NK cell marker
CD56. Almost no CD3
 
1
 
 cells were observed (Fig. 1). Not
only the proportions of CD56
 
1
 
 cells were different, but also
the absolute numbers since 
 
.
 
30-fold more GFP
 
1
 
CD56
 
1
 
cells were found in the FTOC, populated with Id3-trans-
duced CD34
 
1
 
 cells. These data indicate that CD34
 
1
 
 fetal
liver cells, overexpressing Id3, develop preferentially into
CD3
 
2
 
CD56
 
1
 
 cells in the FTOC. It was important to en-
sure that these GFP
 
1
 
CD3
 
2
 
CD56
 
1
 
 cells represent func-
tional NK cells. To obtain enough cells for testing their cy- 
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tolytic activity, we cultured the cells harvested from the
FTOC with a feeder mixture consisting of irradiated PBMCs,
the EBV cell line JY, PHA and IL-2. Under these condi-
tions we can expand NK cells and TCR-
 
g
 
/
 
d
 
, but not
TCR-
 
a
 
/
 
b
 
 cells from an FTOC (24); the failure to obtain
TCR-
 
a
 
/
 
b
 
 cells is because the mouse thymic environment
is unable to induce functional maturation in these cells
(24). Fig. 2 demonstrates that the GFP
 
1
 
 cells expanded
from the control FTOC contained GPF
 
1
 
 TCR 
 
g
 
/
 
d
 
1
 
 cells
and a few CD56
 
1
 
CD3
 
2
 
 cells. By contrast, GFP
 
1
 
 cells ex-
panded from the FTOC with the Id3
 
1
 
 progenitor cells
were CD56
 
1
 
 and did not express CD3, underscoring the
strong inhibitory effect of Id3 on generation of TCR-
 
g
 
/
 
d
 
1
 
cells. The GFP
 
1
 
CD3
 
2
 
CD56
 
1
 
 cells were sorted from the
Id3-IRES-GFP cultures and were shown to be highly cy-
totoxic for the NK sensitive target cell K562, but not for an
NK-resistant cell line (Fig. 2 
 
b
 
). These results confirm that
the CD56
 
1
 
CD3
 
2
 
GFP
 
1
 
 cells observed in these FTOC are
functional NK cells.
The observation that the proportion of CD56
 
1
 
 cells in
the Id3-GFP
 
1
 
 progeny is much higher than in the control
GFP progeny and in the Id3-GFP
 
2
 
 cells in the FTOC is
consistent with the notion that Id3 overexpression switches
the cell fate of the bipotential thymic T/NK progenitors.
An alternative possibility is that overexpression of Id3 con-
fers a growth or survival advantage to developing NK cells
resulting in an overrepresentation of these cells in the
FTOC. To investigate this, we studied the effect of Id3
transduction on development of CD34
 
1
 
 fetal liver cells
into NK cells in a mixture of SCF, IL-7, and IL-2 (2). All
cells generated from transduced CD34
 
1
 
 fetal liver cells and
cultured with the cytokines for 2 wk were CD3
 
2
 
 (not
shown). In both Id3-IRES-GFP and the IRES-GFP cul-
tures, we observed the same proportions of GFP
 
1
 
 cells
(35%) and an identical distribution of CD56 in the IRES-
GFP
 
1
 
 and the Id3-IRES-GFP
 
1
 
 cells (Fig. 3). Thus, consti-
tutive expression of Id3 in the CD341 fetal liver cells does
not significantly enhance the percentage of NK cells that
develop under the influence of SCF, IL-7, and IL-2. This
result makes it unlikely that the increase of NK cell num-
bers observed in the FTOC with Id31 progenitor cells is
caused by improved survival or proliferation by Id3 over-
expression.
TCR-b rearrangements are initiated in the CD1a1
CD32CD42CD82CD341 cells (25, 26). Moreover, CD1a1
cells are unable to develop into NK cells (2). This suggests
that upregulation of CD1a is correlated with T cell com-
mitment. If this is correct and if overexpression of Id3 in-
hibits T cell commitment, we should expect that CD1a2
CD341 cells transduced with Id3 fail to develop into T cells
in an FTOC. Purified CD1a2CD341 cells were cultured
with SCF and IL-7, transduced, and incubated in an FTOC
for 3 wk. Fig. 4 demonstrates that the control-transduced
cells developed normally. By contrast, the proportion of
CD31 cells that developed from Id3-transduced CD1a2
Figure 1. Overexpression of Id3 inhibits generation of T cells and pro-
motes development of NK cells from CD341 fetal liver cells. CD341 cells
were isolated, transduced with viruses harboring IRES-GFP or Id3-IRES-
GFP, and incubated with mouse thymic lobes at 104 cells/lobe for 4 wk.
Cell supensions were stained with the indicated TriColor (TRC) and PE-
labeled antibodies and analyzed on a FACScanÒ. Cell recoveries of both
samples were 3 3 104 cells/lobe. Percentages of transduced cells 2 d after
transduction were 25% in both control- and Id3-transduced samples.
Figure 2. CD561 cells gener-
ated in the FTOC from Id3 trans-
duced CD341 fetal liver cells are
NK cells. (a) Id3- and control-
transduced cells, incubated in an
FTOC, were harvested 4 wk
later, and expanded with a feeder
cell mixture. Percentages of GFP1
cells were 30% for the Id3- and
40% for the control-transduced
cells. (b) GFP1 cells of the Id3-
transduced culture were isolated
by sorting with a FACStar plusÒ
and tested for cytotoxic activity
against NK-sensitive K562 cells
and NK-insensitive EBV 225
cells in a 51Cr–release assay.1600 Id3 Inhibits Human T Cell Development
CD341 cells is strongly reduced, whereas the proportion of
NK cells is dramatically increased. The absolute numbers of
GFP1 NK cells in the Id3-transduced samples was 10-fold
higher than in the GFP1 cells in the control-transduced
samples. The inhibition of generation of CD31 by Id3 is
underscored by the almost complete absence of CD41 and
CD41CD81 in the cells expressing Id3-GFP. The CD81
cells observed in these cultures are CD32CD561 cells. The
Id3-IRES-GFP1CD32CD561 could be expanded with a
feeder cell mixture and displayed cytolytic activity against
K562 cells (results not shown).
Enforced Expression of Id3 Inhibits Induction of D-Jb Rear-
rangement by IL-7 and SCF. T cells are defined by TCR
gene rearrangements; in NK cells, these genes are in the
germ line configuration (1). The fact that Id3 inhibits gen-
eration of CD31 cells and stimulates that of NK cells, raises
the possibility that bHLH factors are required for processes
that result in TCR rearrangements. To test this, we cul-
tured transduced CD1a2CD341 and CD1a1CD341 cells for
7 d in IL-7 and SCF, sorted GFP1 and GFP2 cells, and an-
alyzed for the presence of D-Jb rearrangements with a sen-
sitive PCR technique (25). Fig. 5 shows that Id3 com-
pletely blocked IL-7 and SCF-mediated induction of D-Jb
rearrangement in CD1a2CD341 cells. One trivial explana-
tion for this observation is that SCF and IL-7 induce growth
of a very small population of contaminating CD1a1CD341
cells that have already undergone D-Jb rearrangements; over-
expression of Id3 could inhibit the growth of these con-
taminating cells. This is unlikely because D-Jb rearrange-
ments were still detectable in Id3-transduced CD1a1CD341
cells recovered after 7 d of culture (Fig. 5). The ratios of the
intensities of the bands hybridized with the D-Jb and ge-
nomic DNA control (RAG-2) probes in the starting CD1a1
CD341 (lane 4) and in the Id3-CD1a1CD341 (lane 6) pop-
ulations were the same. This ratio is increased in the un-
transduced CD1a1CD341 cells. These data indicate that
Figure 3. Overexpression of Id3 does not affect NK development and
expansion of CD341 fetal liver cells incubated in IL-2, IL-7, and SCF.
CD341 fetal liver cells were isolated, transduced, and incubated with the
cytokines for 14 d.
Figure 4. Enforced expression of Id3 in
CD1a2CD341 thymocytes blocks T cell
development and promotes NK develop-
ment in an FTOC. CD1a2CD341 thy-
mocytes were isolated from a thymic frag-
ment of a 6-mo-old child, transduced and
incubated in a FTOC for 4 wk at 104 cells/
lobe. Cell recoveries were 5 3 104 and 6 3
104 cells/lobe for the Id3- and the control-
transduced cells, respectively. Percentages of
GFP1 cells 2 d after transduction were 9% in
both samples. Percentages of GFP1 cells,
harvested from the FTOC, were 7.2% in
the control and 2.4% in the Id3-transduced
samples.1601 Heemskerk et al. Brief Definitive Report
Id3 inhibits the IL-7 and SCF-mediated increase DJb rear-
rangements in CD1a1CD341 cells. It appears, therefore,
that Id3 overexpression inhibits induction of D-Jb rear-
rangement. It remains to be determined whether the rear-
rangement process itself is blocked or whether an earlier
step is inhibited. Our results raise the possibility that the
SCF receptor (ckit) and/or the IL-7R communicate with
bHLH factors as suggested previously (14).
The Role of bHLH Factors and Id Proteins in T Cell Devel-
opment. The results presented here indicate that bHLH
proteins are involved in T cell commitment. The critical role
of these factors in T cell commitment is comparable to that
of E2A proteins in commitment of B cells (14) and empha-
sizes the similarities of the mechanisms of early B and T cell
development (27). Several bHLH factors, including E2A,
HEB, and E2-2, can be inhibited in their action by overex-
pression of Id3. Mice with a targeted E2A null mutation
that have no B cells were initially reported to have no ap-
parent gross abnormalities in distribution of double nega-
tive (DN), double positive (DP), and mature thymocytes;
however, the thymi of these mice are relatively small (11,
12). A more recent analysis of the effect of E2A deficiency
on T cell development has revealed that the proportion of
DP cells in the thymus of E2A2/2 mice is lower than in
wild-type or heterozygous E2A2/1 mice. Within the DN
population, an accumulation of CD441CD252 cells and
relatively few CD44low CD251cells was observed (28). Thus
it appears that E2A deficiency results in a partial inhibition
of the CD252 to CD251 transition. Most interestingly, this
transition is equivalent to the CD1a2 to CD1a1 transition
in humans (Blom, B., P.C.M. Res, and H. Spits, manu-
script in preparation) that is blocked by Id3. HEB may be
another target for Id3. Zhuang et al. observed accumula-
tion of DN and less DP thymocytes in the thymus of
HEB2/2 mice (18). Expression of the CD3–TCR complex
on the thymocytes and spleen cells of the HEB-deficient
mice was not analyzed, leaving the developmental stage that
is blocked unresolved. It is possible that HEB, E2A, and
perhaps other bHLH factors collaborate in inducing T cell
development, and that a complete inhibition ensues when
these factors are simultaneously inhibited by overexpression
of Id3. Thus, T cell development may be dictated by a com-
bined dosage of several bHLH factors. It is in this respect
noteworthy that B cell development appears to be regulated
by the combined dosage of E2A, HEB, and E2-2 proteins
(18). Future studies should provide more exact information
about which bHLH factors are critical for T cell develop-
ment and which genes are controlled by these factors.
Figure 5. Enforced expres-
sion of Id3 in CD341CD1a2
thymocytes inhibits induction of
D-Jb rearrangements after incu-
bation in IL-7 and SCF. CD1a2
and CD1a1, CD341 cells were
isolated, transduced, and incubated for 5 d in IL-7 plus SCF. After the in-
cubation, GFP1 and GFP2 cells were isolated from both samples using a
FACStarÒ. Based on GFP expression, the purity of the sorted populations
was .99%. DNA was prepared after the sorting and analyzed for the
presence of D-Jb rearrangements by PCR. The intensities of the hybrid-
ized band were determined with a phosphorimager (Fujix Bas 2000;
Raytest Benelux BV, Straubenherdt, FRG). The ratios of D-J/genomic
control were: lane 1, 0; lane 2, 0.0025; lane 3, 0; lane 4, 0.035; lane 5,
0.062; and lane 6, 0.028.
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